about
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial VirusHemagglutinin-stem nanoparticles generate heterosubtypic influenza protectionA live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuationA subset of membrane-altering agents and γ-secretase modulators provoke nonsubstrate cleavage by rhomboid proteasesCharacterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion GlycoproteinIntramembrane proteolysis of Toxoplasma apical membrane antigen 1 facilitates host-cell invasion but is dispensable for replication.Membrane immersion allows rhomboid proteases to achieve specificity by reading transmembrane segment dynamics.The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton RatsPackaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donorsThe hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody LineagesImmunomodulation Induced by Host Pathogen Interaction
P50
Q27680499-8695E928-5EB2-4EEF-AD8A-DF2A768618A6Q27701887-C833241C-54F8-46EA-8F63-1B41688CA220Q34547769-97FA0B16-9BC4-4F4D-8E30-E8626CEBD231Q35054154-E0DD282B-6F96-4B65-9C64-36A334E75A79Q35687662-42817467-2D1B-41EB-A577-01CCF5C4077CQ35982965-F66EF651-46B8-4822-BCE2-AB4DD2B5E6D8Q36386421-385391F5-27DB-4DEE-9A00-3E1048F4A1D6Q36738014-B875F796-D391-48BD-8C8C-9969E8615940Q37174393-4480F55B-DA84-4471-A3C0-342FEA484387Q37347267-A7FB5EDC-88B1-46A1-B961-85743EBAD83DQ37442017-9441211C-8BE2-4E0B-9253-A699201534C3Q37593886-FB8B050E-9EF3-412F-9554-8608450752A1Q39843921-E97B4402-EC6F-467F-A4B7-D6F94B4F2F09Q40187606-73E7D2E8-8965-4BC6-8569-20826E6AC2EFQ45324052-C5A66FB7-EA0C-4EA2-8CC1-0A8EC2E18C20Q49361412-7DDDF781-8C45-4A8D-B255-AC53CAE6A077Q64102099-53349895-436F-4102-9CEA-81BDFEF54B09Q90358761-89E9C6C2-8AAE-4F95-981C-F7F3B1DF617B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Syed Mohammad Moin
@en
Syed Mohammad Moin
@nl
type
label
Syed Mohammad Moin
@en
Syed Mohammad Moin
@nl
prefLabel
Syed Mohammad Moin
@en
Syed Mohammad Moin
@nl
P31
P496
0000-0001-8789-9167